Canakinumab for low blood sugar after stomach weight-loss surgery
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests whether canakinumab can reduce frequent low blood sugar episodes after bariatric (weight-loss) surgery. It is designed for people who keep having low blood sugar despite dietary changes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had bariatric surgery such as sleeve gastrectomy, Roux-en-Y, omega-loop, or biliopancreatic diversion
- Your low blood sugar has been confirmed (less than 3.0 mmol/L) with at least 5 episodes per week, even after diet changes
- You do not have diabetes by standard medical criteria (including Type 1 or Type 2 diabetes)
- You can use effective birth control if you could become pregnant, and you are not pregnant or breastfeeding
- You are able to follow study visits and procedures, and you can reliably take study treatment as instructed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a drug called anakinra to see if it can prevent severe drops in blood sugar after eating in people who have had their stomach removed. It is designed for one person, so results may not apply to everyone.
This trial tests a medication called mizagliflozin to see if it can reduce episodes of low blood sugar in people who have had gastric bypass surgery. If you experience symptoms like confusion or fainting when your blood sugar drops, this study might help.
This study looks at how food moves through the body and how that may affect episodes of low blood sugar caused by too much insulin. It may help researchers better understand and possibly improve care for people who get hypoglycemia, especially after bariatric (weight-loss) surgery.
This study compares different ways to manage episodes of low blood sugar that can happen after meals in people who have had weight-loss or other stomach surgery. It looks at whether changes in diet, certain medications, or a procedure done with a scope can help prevent these episodes.
This trial tests whether a diabetes medication called dapagliflozin helps smooth out blood sugar swings after bariatric (weight-loss) surgery. It may help people with type 2 diabetes achieve better control after their surgery.
This study looks at how the body handles carbohydrates after eating in people who have had gastric bypass surgery, with or without post-surgery hypoglycemia (low blood sugar). The goal is to understand why some people get low blood sugar after meals and how to better manage it.
Hear when a new Postprandial Hypoglycemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.